Toshiba America Medical Systems used a little marketing pizzazzto unveil an adjustable-angle dual-head gamma camera as a work-in-progressat this month's Society of Nuclear Medicine meeting in Toronto.Rather than display an empty mock-up of the camera,
Toshiba America Medical Systems used a little marketing pizzazzto unveil an adjustable-angle dual-head gamma camera as a work-in-progressat this month's Society of Nuclear Medicine meeting in Toronto.Rather than display an empty mock-up of the camera, TAMS useda 3-D interactive laser-disk presentation to walk convention-goersthrough the camera's applications. The technique is both glitzyand cost-effective.
"Using the interactive display, we can clearly demonstratehow the system will operate in the clinical environment and wecan do that at a substantially lower exhibition cost," saidSteve Sickels, manager of TAMS' nuclear medicine unit. "Intoday's market environment, we felt that this is a more appropriateproduct demonstration technique."
The product presentation consisted of a four-minute video andinteractive 3-D laser-disk program. The video displayed 10 dual-headprocedures possible with the GCA-7200 camera, including off-tableimaging, whole-body studies, single-photon emission computed tomographyand SPECT immediately after whole body. Laser-disk technologyoffers viewers instant access to the desired segment.
The GCA-7200 will be the Tustin, CA-based Toshiba's first nuclearcamera with adjustable detectors, Sickels said. Toshiba currentlymarkets a fixed-angle dual-head unit, the GCA-901A/HG. While theGCA-7200 is more versatile than its predecessor, it will not perform90´-angle studies as do variable-angle cameras from ADACand Sopha.
The unit will also be Toshiba's first gamma camera to use thevendor's Robocontour feature, in which infrared sensors adjustdetectors to within 2 cm of a patient's body shape. Robocontourworks on the fly, without requiring trial runs for the systemto "learn" the contour of the patient's body.
The camera will operate on Sun SPARC 2E architecture, and willeventually be upgraded to the Sun SPARC 10. Toshiba is also upgradingits HG Series nuclear medicine workstation line to Sun SPARC 10,which will enable faster menu selection for users.
Toshiba filed for Food and Drug Administration 510(k) clearancefor the system in March and hopes to begin marketing the unitby the end of this year.
In other Toshiba news, TAMS named Ravi D. Sharma as vice presidentof marketing last month. Sharma most recently held the positionof vice president of service. He joined the company in 1989.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.